Content about FOREST

August 30, 2012

Generic drug maker Hospira has acquired a manufacturing and research and development center from an Indian drug maker for $200 million, Hospira said Wednesday.

LAKE FOREST, Ill. — Generic drug maker Hospira has acquired a manufacturing and research and development center from an Indian drug maker for $200 million, Hospira said Wednesday.

Hospira said it bought the Food and Drug Administration-approved active pharmaceutical ingredient factory and R&D facility in Aurangabad, India, from Orchid Chemicals and Pharmaceuticals, saying it would reduce Hospira's costs, support its supplying of antibiotics and pave the way for future API development.

August 30, 2012

Kirby Lester will provide pharmacy automation equipment for a distribution company based in Tennessee.

LAKE FOREST, Ill. — Kirby Lester will provide pharmacy automation equipment for a distribution company based in Tennessee.

Kirby Lester announced that its KL60 compact robotic dispenser would provide its KL60 compact robotic dispenser, which would be the exclusive pharmacy automation for Tri State Distribution's TriMaxx three-sided container, closer and label system. The companies announced the deal before the National Association of Chain Drug Stores' Pharmacy and Technology Conference in Denver, which ended Tuesday.

August 9, 2012

Hospira has relaunched a generic chemotherapy drug for the U.S. market, the generic drug maker said Thursday.

LAKE FOREST, Ill. — Hospira has relaunched a generic chemotherapy drug for the U.S. market, the generic drug maker said Thursday.

The company, which specializes in generic injectables, announced the relaunch of oxaliplatin, a version of Sanofi's Eloxatin.

August 9, 2012

At-home gel polish brand SensatioNail has launched its new SensatioNail Gel Polish Removal Kit and Gel Polish Removal Tool.

LAKE FOREST, Calif. — At-home gel polish brand SensatioNail has launched its new SensatioNail Gel Polish Removal Kit and Gel Polish Removal Tool.

"Our mission is to empower women with the tools they need to achieve salon results at home," stated SensatioNail SVP marketing and research and development Marwan Zreik. "We understand that women want to take beauty into their own hands, and that is why we are pioneering accessible, affordable offerings in the nail category."

April 19, 2012

The Dr Pepper Snapple Group has inked a multiyear deal with a National Football League franchise.

LAKE FOREST, Ill. — The Dr Pepper Snapple Group has inked a multiyear deal with a National Football League franchise.

March 2, 2012

To help Americans walk more, Omron Healthcare and Bob Greene, Oprah Winfrey's personal trainer and author of the book "20 Years Younger," on Friday teamed to create four new videos to encourage Americans to put a spring in their step and start tracking their progress daily.

LAKE FOREST, Ill. — To help Americans walk more, Omron Healthcare and Bob Greene, Oprah Winfrey's personal trainer and author of the book "20 Years Younger," on Friday teamed to create four new videos to encourage Americans to put a spring in their step and start tracking their progress daily.

February 24, 2012

Generic drug maker Hospira has joined the country's largest lobby for the generic drug industry, the company said.

LAKE FOREST, Ill. — Generic drug maker Hospira has joined the country's largest lobby for the generic drug industry, the company said.

Hospira, which specializes in generic injectables and infusion technology, announced that it had joined the Generic Pharmaceutical Association. In addition to generic pharmaceuticals, the company also makes biosimilars for the European market.

January 10, 2012

Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

LAKE FOREST, Ill. — Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

The company said the phase-3 trial of biosimilar EPO (erythropoietin) would compare its product with Amgen's Epogen in patients with kidney dysfunction who have anemia. The trial, which will enroll about 1,000 patients who already have taken Epogen, follows a phase-1 trial that ended last year, and results of the late-stage trial are expected next year.

November 17, 2011

Nail and beauty care company Pacific World officially has announced the launch of its new SensatioNail Invincible Gel Polish under the Nailene brand.

LAKE FOREST, Calif. — Nail and beauty care company Pacific World officially has announced the launch of its new SensatioNail Invincible Gel Polish under the Nailene brand.

SensatioNail is a collection of at-home gel polish products that will provide users with up to two weeks of damage-proof wear.

November 4, 2011

Pacific World, a manufacturer of nail and beauty care products, has merged with W.E. Bassett Co., a supplier of beauty implements, creating the fifth-largest cosmetics company and second-largest nail care company by sales in food, drug and mass retailers nationwide.

LAKE FOREST, Calif. — Pacific World, a manufacturer of nail and beauty care products, has merged with W.E. Bassett Co., a supplier of beauty implements, creating the fifth-largest cosmetics company and second-largest nail care company by sales in food, drug and mass retailers nationwide.

September 12, 2011

GeoGirl, a new line of color cosmetics and skin care designed by Pacific World for “Generation Z,” has announced that Drugstore.com now will carry its complete line.

LAKE FOREST, Calif. — GeoGirl, a new line of color cosmetics and skin care designed by Pacific World for “Generation Z,” has announced that Drugstore.com now will carry its complete line.

The 69-SKU collection includes makeup for face, lips, cheeks and eyes, plus skin and body care, with suggested retail prices ranging from $4.29 to $6.39.

August 9, 2011

The Food and Drug Administration has approved a generic chemotherapy drug made by Hospira, the drug maker said.

LAKE FOREST, Ill. — The Food and Drug Administration has approved a generic chemotherapy drug made by Hospira, the drug maker said.

Hospira announced the approval of gemcitabine injection in the 200-mg, 1-g and 2-g formulations and plans to launch the drug in September. The drug is a generic version of Eli Lilly's Gemzar.

Various versions of the drug had sales of $750 million in 2010, according to Hospira.

May 6, 2011

Akorn, a niche generic pharmaceutical company, earlier this week entered into an agreement to acquire Advanced Vision Research, an over-the-counter ophthalmic company that promotes eye care products under the TheraTears and MacuTrition brands.

LAKE FOREST, Ill. — Akorn, a niche generic pharmaceutical company, earlier this week entered into an agreement to acquire Advanced Vision Research, an over-the-counter ophthalmic company that promotes eye care products under the TheraTears and MacuTrition brands.

April 26, 2011

Hospira had net sales of $1 billion during first quarter 2011, the generic drug maker said Tuesday.

LAKE FOREST, Ill. — Hospira had net sales of $1 billion during first quarter 2011, the generic drug maker said Tuesday.

Sales for the quarter, which ended March 31, declined by 0.5%, compared with first quarter 2010, while profits were $149.9 million, a 5.8% increase over last year.

March 10, 2011

Hospira has received approval from the Food and Drug Administration for a generic cancer treatment.

LAKE FOREST, Ill. — Hospira has received approval from the Food and Drug Administration for a generic cancer treatment.

Hospira will offer 20-mg, 80-mg and 160-mg vials of docetaxel at a 10-mg/mL concentration. Docetaxel is a generic version of Sanofi-Aventis's Taxotere.

Hospira already markets docetaxel in Europe and Australia, the drug maker noted.

March 8, 2011

Generic drug maker Hospira has appointed Mike Ball as CEO, effective March 28, the company said. Ball currently is president of Allergan.

LAKE FOREST, Ill. — Generic drug maker Hospira has appointed Mike Ball as CEO, effective March 28, the company said. Ball currently is president of Allergan.

Ball, who also was appointed to the company’s board, will replace Christopher Begley, who will assume the role of executive chairman.

March 4, 2011

Hospira launched a new online resource that catalogs all of its products available in the United States.

LAKE FOREST, Ill. — Hospira launched a new online resource that catalogs all of its products available in the United States.

Hospira said that the U.S. product catalog, available at Hospira.com/catalog, allows customers, including healthcare facilities and medical care providers, to search Hospira's more than 1,200 products in a variety of ways: alphabetically, by product name, by list number or by therapeutic class.

February 7, 2011

The Food and Drug Administration has approved a generic cancer drug from Hospira.

LAKE FOREST, Ill. — The Food and Drug Administration has approved a generic cancer drug from Hospira.

The drug maker announced the approval of topotecan injection for treating small-cell lung cancer sensitive disease after first-line chemotherapy has failed.

The drug is a generic version of GlaxoSmithKline’s Hycamtin, which had sales of more than $140 million in 2010, according to Hospira.

January 11, 2011

A new line of nitrile disposable examination gloves is hitting the market.

LAKE FOREST, Ill. — A new line of nitrile disposable examination gloves is hitting the market.

Microflex's Xceed gloves offer a unique combination of benefits for any disposable examination glove user (nitrile or latex) looking to increase glove quality and durability at an affordable price. The gloves mimic the soft fit, feel and tactile sensitivity of disposable natural rubber latex gloves, while delivering up to 90% greater tensile strength.

January 5, 2011

Pactiv is rolling out a line of compostable paper plates for its Hefty brand.

LAKE FOREST, Ill. — Pactiv is rolling out a line of compostable paper plates for its Hefty brand.

Hefty Basics are disposable paper plates that have the strength to support almost any meal. The plates are biodegradable in home composting and are microwavable, Pactiv said.

The plates are available at select grocery stores throughout the Northeast region of the United States in 45-count, 8 and 5/8-in. lunch plate packages and 24-count, 10 and 1/4-in. dinner plate packages.

November 22, 2010

A drug maker has named a former executive at Tengion to the newly created post of SVP quality ...

LAKE FOREST, Ill. A drug maker has named a former executive at Tengion to the newly created post of SVP quality.

Hospira said Francois Dubois would be responsible for the global specialty pharmaceutical and medication delivery company's global quality systems, and will serve as a member of Hospira's senior leadership team. Dubois will report directly to Christopher Begley, Hospira's chairman and CEO.

November 15, 2010

Generic injectable drug maker Hospira has launched a version of a chemotherapy drug, the company...

LAKE FOREST, Ill. Generic injectable drug maker Hospira has launched a version of a chemotherapy drug, the company said Monday.

 

Hospira announced the launch of gemcitabine hydrochloride in 2-g vials, a generic version of Eli Lilly’s Gemzar.

 

 

Gemzar had sales of nearly $750 million in 2009, according to Hospira.

 

October 25, 2010

The temporary discontinuation of sales of a drug used by cancer patients led to a...

LAKE FOREST, Ill. The temporary discontinuation of sales of a drug used by cancer patients led to a slight dip in sales for Hospira during third quarter 2010, but the company nonetheless had strong sales overall, according to an earnings report released Tuesday.

 

October 21, 2010

Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday....

LAKE FOREST, Ill. Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday.

 

The company, which specializes in generic injectables, announced the launch of piperacillin and tazobactam for injection. The drug is a generic version of Pfizer’s Zosyn.

 

 

Various versions of the drug had sales of $797 million during the 12-month period ended in August, according to IMS Health. Sandoz, the generics division of Novartis, also launched its own version of the drug Thursday.

August 19, 2010

Hospira chairman and CEO Chris Begley will retire from his CEO position, Hospira said Friday....